Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To evaluate the long-term safety and efficacy of pregabalin in patients with partial seizures.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pregabalin | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Safety Efficacy |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pfizer CT.gov Call Center | Pfizer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pfizer Investigational Site | Birmingham | Alabama | 35249 | United States | ||
| Pfizer Investigational Site |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Birmingham |
| Alabama |
| 35255 |
| United States |
| Pfizer Investigational Site | Birmingham | Alabama | 35294-0021 | United States |
| Pfizer Investigational Site | Phoenix | Arizona | 85006 | United States |
| Pfizer Investigational Site | Tucson | Arizona | 85712-2809 | United States |
| Pfizer Investigational Site | Tucson | Arizona | 85712 | United States |
| Pfizer Investigational Site | Little Rock | Arkansas | 72205 | United States |
| Pfizer Investigational Site | Los Angeles | California | 90033 | United States |
| Pfizer Investigational Site | Pasadena | California | 91105 | United States |
| Pfizer Investigational Site | Gainesville | Florida | 32608-1197 | United States |
| Pfizer Investigational Site | Gainesville | Florida | 32610 | United States |
| Pfizer Investigational Site | Miami | Florida | 33136 | United States |
| Pfizer Investigational Site | Plantation | Florida | 33317 | United States |
| Pfizer Investigational Site | Spring Hill | Florida | 34609 | United States |
| Pfizer Investigational Site | Tallahassee | Florida | 32308 | United States |
| Pfizer Investigational Site | Chicago | Illinois | 60612 | United States |
| Pfizer Investigational Site | Springfield | Illinois | 62702 | United States |
| Pfizer Investigational Site | Springfield | Illinois | 62704 | United States |
| Pfizer Investigational Site | Indianapolis | Indiana | 46202 | United States |
| Pfizer Investigational Site | Indianapolis | Indiana | 46254 | United States |
| Pfizer Investigational Site | Iowa City | Iowa | 52242 | United States |
| Pfizer Investigational Site | Kansas City | Kansas | 66160-7314 | United States |
| Pfizer Investigational Site | Kansas City | Kansas | 66160 | United States |
| Pfizer Investigational Site | Louisville | Kentucky | 40205 | United States |
| Pfizer Investigational Site | Baltimore | Maryland | 21201 | United States |
| Pfizer Investigational Site | Baltimore | Maryland | 21224 | United States |
| Pfizer Investigational Site | Greenbelt | Maryland | 20770 | United States |
| Pfizer Investigational Site | Boston | Massachusetts | 02130 | United States |
| Pfizer Investigational Site | Boston | Massachusetts | 02215 | United States |
| Pfizer Investigational Site | Ann Arbor | Michigan | 48108 | United States |
| Pfizer Investigational Site | Ann Arbor | Michigan | 48109 | United States |
| Pfizer Investigational Site | Saint Paul | Minnesota | 55102 | United States |
| Pfizer Investigational Site | Chesterfield | Missouri | 63017 | United States |
| Pfizer Investigational Site | Columbia | Missouri | 65212 | United States |
| Pfizer Investigational Site | St Louis | Missouri | 63110-1092 | United States |
| Pfizer Investigational Site | St Louis | Missouri | 63110 | United States |
| Pfizer Investigational Site | Lebanon | New Hampshire | 03756 | United States |
| Pfizer Investigational Site | New York | New York | 10016 | United States |
| Pfizer Investigational Site | New York | New York | 10032 | United States |
| Pfizer Investigational Site | Rochester | New York | 14642 | United States |
| Pfizer Investigational Site | Winston-Salem | North Carolina | 27157 | United States |
| Pfizer Investigational Site | Cleveland | Ohio | 44195 | United States |
| Pfizer Investigational Site | Columbus | Ohio | 43210 | United States |
| Pfizer Investigational Site | Portland | Oregon | 97227 | United States |
| Pfizer Investigational Site | Nashville | Tennessee | 37232 | United States |
| Pfizer Investigational Site | Dallas | Texas | 75230 | United States |
| Pfizer Investigational Site | San Antonio | Texas | 78229 | United States |
| Pfizer Investigational Site | Bennington | Vermont | 05201 | United States |
| Pfizer Investigational Site | Edmonton | Alberta | T5H 3V9 | Canada |
| Pfizer Investigational Site | Edmont | Alberta | T5G 0B7 | Canada |
| Pfizer Investigational Site | Vancouver | British Columbia | V52 1M9 | Canada |
| Pfizer Investigational Site | Vancouver | British Columbia | V67 1Y6 | Canada |
| Pfizer Investigational Site | London | Ontario | N6A 5A5 | Canada |
| Pfizer Investigational Site | Ottawa | Ontario | K1H 8L6 | Canada |
| Pfizer Investigational Site | Toronto | Ontario | M4Y 1J3 | Canada |
| Pfizer Investigational Site | Montreal | Quebec | H3A 2B4 | Canada |
| ID | Term |
|---|---|
| D004828 | Epilepsies, Partial |
| ID | Term |
|---|---|
| D004827 | Epilepsy |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000069583 | Pregabalin |
| ID | Term |
|---|---|
| D005680 | gamma-Aminobutyric Acid |
| D000613 | Aminobutyrates |
| D002087 | Butyrates |
| D000144 | Acids, Acyclic |
| D002264 | Carboxylic Acids |
| D009930 | Organic Chemicals |
| D000596 | Amino Acids |
| D000602 | Amino Acids, Peptides, and Proteins |
Not provided
Not provided